share_log

12 Health Care Stocks Moving In Monday's Pre-Market Session

Benzinga ·  Mar 4 08:09

Gainers

  • Quoin Pharmaceuticals (NASDAQ:QNRX) stock rose 71.1% to $4.74 during Monday's pre-market session. The market value of their outstanding shares is at $4.6 million.
  • Ainos (NASDAQ:AIMD) shares moved upwards by 69.52% to $1.78. The market value of their outstanding shares is at $8.3 million.
  • Helius Medical Tech (NASDAQ:HSDT) shares increased by 55.04% to $7.07. The market value of their outstanding shares is at $6.2 million.
  • Renalytix (NASDAQ:RNLX) stock rose 43.26% to $1.49. The market value of their outstanding shares is at $74.4 million.
  • 89bio (NASDAQ:ETNB) shares rose 38.66% to $17.5. The company's market cap stands at $1.6 billion. As per the news, the Q4 earnings report came out 2 days ago.
  • Jaguar Health (NASDAQ:JAGX) stock moved upwards by 37.17% to $0.12. The company's market cap stands at $6.1 million.

Losers

  • BioVie (NASDAQ:BIVI) stock declined by 46.0% to $1.02 during Monday's pre-market session. The market value of their outstanding shares is at $40.6 million.
  • First Wave BioPharma (NASDAQ:FWBI) shares declined by 29.44% to $6.52. The company's market cap stands at $10.1 million.
  • Sunshine Biopharma (NASDAQ:SBFM) stock decreased by 21.49% to $0.04. The company's market cap stands at $2.3 million.
  • Adial Pharmaceuticals (NASDAQ:ADIL) shares decreased by 15.65% to $2.75. The company's market cap stands at $4.5 million.
  • Akili (NASDAQ:AKLI) stock decreased by 10.06% to $0.31. The market value of their outstanding shares is at $24.6 million. As per the press release, Q4 earnings came out 2 days ago.
  • Bone Biologics (NASDAQ:BBLG) shares declined by 9.88% to $2.19. The company's market cap stands at $1.1 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment